Prelude Capital Management, LLC Trevena Inc Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $37,689 - $58,083	-25,815 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.77 - $2.93 $45,692 - $75,637	25,815 New	25,815 $46,000
Q4 2017 Feb 14, 2018	SELL	$1.4 - $2.6 $13,440 - $24,960	-9,600 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $21,312 - $26,784	9,600	9,600 $24,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.